Characteristic | Enrolled in survey N = 1537 n (%) | Included for molecular analysis N = 973 n (%) | Not included for molecular analysis N = 564 n (%) | p-value | |
---|---|---|---|---|---|
Sex | Male | 1018 (66.2) | 630 (64.7) | 388 (68.8) | 0.106 |
Female | 519 (33.8) | 343 (35.3) | 176 (31.2) | ||
Age | 13-14 | 33 (2.2) | 21 (2.2) | 12 (2.1) | 0.956 |
15-24 | 299 (19.5) | 189 (19.8) | 108(19.2) | ||
25-34 | 521 (33.4) | 330 (34.3) | 191 (34.0) | ||
35-44 | 366 (23.8) | 235 (24.5) | 131 (23.3) | ||
45-54 | 167 (10.9) | 100 (10.4) | 67 (11.9) | ||
>55 | 139 (9.0) | 86 (9.0) | 53 (9.43) | ||
HIV already diagnosed positive | Yes | 339 (22.1) | 217 (22.3) | 122 (21.6) | 0.586 |
No | 873 (53.6) | 527 (54.2) | 296 (52.5) | ||
Unknown | 375 (24.4) | 229 (23.5) | 146 (25.9) | ||
TB control Zone | South West | 482 (31.4) | 278 (28.6) | 204 (36.2) | 0.004 |
Kampala | 457 (29.7) | 313 (31.2) | 144 (25.5) | ||
South East | 97 (6.3) | 59 (6.1) | 38 (6.7) | ||
Eastern | 53 (3.5) | 28 (2.9) | 25 (4.4) | ||
North East | 152 (9.9) | 89 (9.2) | 63 (11.2) | ||
North | 52 (3.4) | 36 (3.7) | 16 (2.8) | ||
North West | 149 (9.7) | 104 (10.7) | 45 (8.0) | ||
Western | 95 (6.2) | 66 (6.8) | 29 (5.1) | ||
HIV results at (re)testing | Positive | 469 (30.5) | 297 (30.5) | 172 (30.5) | 0.216 |
Negative | 1054 (68.6) | 664 (68.2) | 390 (69.2) | ||
Missing | 14 (0.91) | 12 (1.23) | 2 (0.35) | ||
Previous TB treatment | Yes | 140 (9.2) | 78 (8.1) | 62 (11.3) | 0.057 |
No | 1397 (90.8) | 883 (91.9) | 500 (89.0) |